Ondansetron Solution for Injection 2 Mg/Ml in 4 Tender - 138863689

Procurement Summary

Country: Ukraine

Summary: Ondansetron Solution for Injection 2 Mg/Ml in 4 Ml; Lactulose Syrup 3.335 G/5 Ml Bottle 200 Ml; Activated Charcoal Tablets/Capsules of 250 Mg Each; Loperamide 2 Mg Tablets/Capsules; Nifuroxazide Tablets/Caps...

Deadline: 31 Jul 2026

Posting Date: 02 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 138863689

Document Ref. No.: UA-2026-04-01-000895-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 1378562.43

CPV Classification

33600000 - Pharmaceutical products
33610000 - Medicinal products for the alimentary tract and metabolism

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Ondansetron solution for injection 2 mg/ml in 4 ml; Lactulose syrup 3.335 g/5 ml bottle 200 ml; Activated charcoal tablets/capsules of 250 mg each; Loperamide 2 mg tablets/capsules; Nifuroxazid 200 mg tablets/capsules; Pancreatin, Lipolytic Units: 10, 000; Insulin human (Short duration of action), solution for injection, 100 Units/ml, bottle, 10 ml each; Metformin tablets/capsules of 500 mg; Hydrogen peroxide, solution, 3%, 40 ml each; Octreotide solution for injection 0.1 mg/ml in 1 ml; Potassium asparaginate/Magnesium asparaginate solution for injections of 10 ml each; Калію аспарагінат/Магнію таблетки; Клопідогрел, таблетки, вкриті оболонкою, по 75 мг; Ammonia, solution for external use, 10%, 40 ml each; Enoxaparin sodium, solution for injection, 10, 000 anti-Xa IU/ml, 0.4 ml each; Enoxaparin sodium, injection solution, 10, 000 anti-Xa IU/ml, 0.8 ml each; Ethamsylate solution for injection, 125 mg/ml in 2 ml; Norepinephrine, concentrate for solution for infusions, 2 mg/ml in 4 ml; Folic acid 1 mg tablets; Thiopental, powder/lyophilisate, 1 g each; Calcium chloride solution for injection, 100 mg/ml 10 ml; Nitroglycerin, sublingual tablets, 0.5 mg each; Salts for oral rehydration, powder for oral solution, 18.9 g each; Sodium heparin, gel, 1000 IU/g, 50 g each; Diosmin (combinations), tablets, 1000 mg each; Metoprolol 50 mg tablets; Bisoprolol tablets 10 mg each; Lisinopril 10 mg tablets; Perindopril/indapamide/amlodipine tablets 8 mg/2.5 mg/5 mg; Terbinafine, tablets, 250 mg each; Fluconazole, tablets/capsules, 2... Type of purchase: goods Classifier and its relevant code: DC 021:2015: 33600000-6 — Pharmaceutical products Ondansetron solution for injections 2 mg/ml in 4 ml; Metformin: Classification according to ATX: A10BA02, Classification according to INN: Metformin, Release form: Tablets, Tablets, coated with a shell, Capsules, Dose of the active substance: 500 mg, Packaging type: Blister; Hydrogen peroxide, solution, 3%, 40 ml each; Potassium asparaginate/Magnesi...

Documents

 Tender Notice